The Why Behind In-House Manufacturing With Sangamo's Andy Ramelmeier
Source: Cell & Gene
On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Andy Ramelmeier, EVP Head of Technical Operations at Sangamo Therapeutics, a biotech based in Brisbane, California that applies cell and gene therapy to combat Hemophilia A and other genetic diseases. Ramelmeier explains the why behind the company's decision to build its own Phase 1/2 cGMP AAV in-house facility. He also talks broadly about manufacturing cell and gene therapies and the potential and realistic solutions to needed to drive down manufacturing costs.
Find Cell & Gene: The Podcast wherever you get your podcasts.
This website uses cookies to ensure you get the best experience on our website. Learn more